QQ客服 官方微博 反馈留言

	The risk of immune-related endocrine disorders associated with anti-PD-1 inhibitors therapy for solid tumors: A systematic review and meta-analysis
	Su, Qiang; Zhang, Xiao-chen; Wang, Di-ya; Zhang, Huai-rong; Zhu, Cheng; Hou, Yan-li; Liu, Jun-li; Gao, Zu-hua
刊名	INTERNATIONAL IMMUNOPHARMACOLOGY
	2018
卷号	59页码:328-338
关键词	Immune-related endocrine disorders PD-1 inhibitor Meta-analysis
ISSN号	1567-5769
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2921924
专题	西安交通大学
推荐引用方式 GB/T 7714	Su, Qiang,Zhang, Xiao-chen,Wang, Di-ya,et al. The risk of immune-related endocrine disorders associated with anti-PD-1 inhibitors therapy for solid tumors: A systematic review and meta-analysis[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2018,59:328-338.
APA	Su, Qiang.,Zhang, Xiao-chen.,Wang, Di-ya.,Zhang, Huai-rong.,Zhu, Cheng.,...&Gao, Zu-hua.(2018).The risk of immune-related endocrine disorders associated with anti-PD-1 inhibitors therapy for solid tumors: A systematic review and meta-analysis.INTERNATIONAL IMMUNOPHARMACOLOGY,59,328-338.
MLA	Su, Qiang,et al."The risk of immune-related endocrine disorders associated with anti-PD-1 inhibitors therapy for solid tumors: A systematic review and meta-analysis".INTERNATIONAL IMMUNOPHARMACOLOGY 59(2018):328-338.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。